欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0121/001
药品名称
Oxis Turbuhaler
活性成分
formoterol fumarate 4.5 µg/dose
剂型
Inhalation powder
上市许可持有人
AstraZeneca AB Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Germany (DE)
Denmark (DK)
Belgium (BE)
Netherlands (NL)
Luxembourg (LU)
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Austria (AT)
Oxis Turbohaler 6 µg - Dosier-Pulverinhalator
Spain (ES)
Portugal (PT)
Oxis Turbohaler
Italy (IT)
Greece (GR)
Finland (FI)
许可日期
1997/03/03
最近更新日期
2024/02/09
药物ATC编码
R03AC13 formoterol
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
Full Dossier Article 4.8 Di 65/65
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final PL
|
SE_H_0121_001_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_0121_001_Final SPC
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase